Small or Large, We Delivery ALL
It’s all about DELIVERY
The research projects are centered on the interface of polymers and therapeutics at the nano-micro or macro-scale to prevent, manage or treat diseases using drugs or drug-like compounds or their combinations. The idea is to apply innovative delivery strategies to the existing small or large molecules for improving the risk vs benefit ratio; realize new indications or apply the innovative delivery technologies early on in the drug discovery program to minimize the attrition rates. Examples of some ongoing projects: Project-1: Systemic anti-inflammatory therapy to prevent or delay diabetic cataracts and treat post-surgical inflammation; Project-2: Oral delivery of insulin using ligand-directed nanoparticles that do not compete with physiological ligands; Project-3: Engineering the next generation nanoparticle-cyclosporine A therapy in lupus.
Current Research is Funded by